Braun SE is a medical technology company that manufactures medical devices and pharmaceutical products. Its portfolio consists of products such as infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, and ostomy, disinfection, and wound care products. The company operates its business through three divisions – Hospital Care, Aesculap, and Avitum. The Hospital Care division is a supplier of infusion, nutrition and pain therapy products. For infusion therapy, it offers system solutions comprising drugs and single-use products, and smart medical device systems. The nutritional therapy portfolio contains parenteral and enteral nutrition products, besides drink solutions. In pain therapy, the company’s focus is on regional anaesthesia. The Aesculap division is a partner for surgical and interventional treatment concepts in inpatient and ambulatory care. The company bundles its business into the therapeutic areas of minimally invasive surgery, orthopaedic surgery and spine surgery, neurosurgery, interventional vascular therapy, sterile goods management, and surgical specialties. Its portfolio also includes suture materials, surgical adhesives, mechanical staple guns, and endoluminal vacuum therapy.
The Avitum division focuses on people with chronic and acute kidney failure. It offers products and services in three areas – hemodialysis, acute dialysis, and apheresis. B. Braun concentrates on therapies such as continence care and urology, extracorporeal blood treatment therapies, infection prevention and control, minimally invasive surgery, and orthopaedic surgery.